| A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis (NCT01085097) | Teva Branded Pharmaceutical Products R&D, Inc. | 2010-09-01 |
| Velcade for Proliferative Lupus Nephritis (NCT01169857) | The Rogosin Institute | 2010-08-01 |
| Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus Nephritis (NCT01203709) | Tuen Mun Hospital | 2010-08-01 |
| Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus Nephritis (NCT01056237) | Zhi-Hong Liu, M.D. | 2010-02-01 |
| The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis (NCT01015456) | Chulalongkorn University | 2010-01-01 |
| Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis (NCT01042457) | Chulalongkorn University | 2009-05-01 |
| Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria (NCT00935389) | Nanjing University School of Medicine | 2009-04-01 |
| Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis (NCT00876616) | Zhi-Hong Liu, M.D. | 2009-04-01 |
| To Compare the Efficacy and Safety of Tripterygium (TW) Versus AZA in the Maintenance Therapy for Lupus Nephritis (NCT00881309) | Nanjing University School of Medicine | 2009-03-01 |
| Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis (NCT00908986) | Northwell Health | 2008-12-01 |
| Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis (NCT00774852) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-01 |
| Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis (NCT00659217) | Organ Transplant Institute, China | 2008-05-01 |
| A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG) (NCT00626197) | Genentech, Inc. | 2008-02-15 |
| The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis (NCT00573157) | EMD Serono | 2007-12-01 |
| A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis (NCT00569101) | Seoul National University Hospital | 2007-09-01 |
| A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations (NCT01410747) | Astellas Pharma Inc | 2007-04-10 |
| A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis. (NCT00425438) | Hoffmann-La Roche | 2007-03-01 |
| Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare (NCT00423098) | Novartis Pharmaceuticals | 2007-02-01 |
| Phase Ib Study of SC Milatuzumab in SLE (NCT01845740) | Gilead Sciences | 2007-01-01 |
| TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL ) (NCT00368264) | Medical University of Vienna | 2006-09-01 |
| Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis (NCT00615173) | Sun Yat-sen University | 2006-07-01 |
| A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis (NCT02081183) | Hoffmann-La Roche | 2006-03-01 |
| A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus Nephritis (NCT00282347) | Genentech, Inc. | 2006-01-01 |
| A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis (NCT00404794) | Hospital Authority, Hong Kong | 2005-11-01 |
| Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V) (NCT00298506) | Nanjing University School of Medicine | 2005-09-01 |
| Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis (NCT00371319) | Tuen Mun Hospital | 2005-09-01 |
| A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis. (NCT00377637) | Hoffmann-La Roche | 2005-07-01 |
| Study of LJP 394 in Lupus Patients With History of Renal Disease (NCT00089804) | La Jolla Pharmaceutical Company | 2004-10-01 |
| Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) (NCT00094380) | National Institute of Allergy and Infectious Diseases (NIAID) | 2004-09-01 |
| To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN (NCT00302549) | Nanjing University School of Medicine | 2004-05-01 |
| Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis (NCT00125307) | Chinese University of Hong Kong | 2004-01-01 |
| Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis (NCT00709722) | Nippon Kayaku Co., Ltd. | 2003-10-01 |
| Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study (NCT00429377) | Astellas Pharma Inc | 2003-06-01 |
| Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis (NCT01207297) | Zhejiang University | 2003-03-01 |
| Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study (NCT00976300) | Institute of Rheumatology, Prague | 2002-01-01 |
| Lupus Nephritis: Role of Environmental and Occupational Exposures (NCT00342329) | National Institute of Environmental Health Sciences (NIEHS) | 2001-04-16 |
| Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis. (NCT00204022) | Frédéric A. Houssiau, MD, PhD | 2001-02-01 |
| BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis (NCT00001789) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1999-06-01 |
| Cyclophosphamide and Fludarabine to Treat Lupus Nephritis (NCT00001676) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1998-01-01 |
| Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis (NCT00539799) | Cambridge University Hospitals NHS Foundation Trust | |
| A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Lupus Nephritis Previously Enrolled in Study U2970g (NCT00404157) | Genentech, Inc. | |